PALVELLA THERAPEUTICS, INC.

PVLA

PALVELLA THERAPEUTICS, INC.

PVLA

Insider Sentiment (TTM):

Last Purchase:2026-03-30Last Sale:2026-06-17Shares Purchased (TTM):6,845Shares Sold (TTM):34,416

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:12,767,444Shares Outstanding:13,085,271Institutional Ownership Pct.:97.57%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	188	206	58	64	70	76	84	19	20	19	7	33
Accounts Receivable Net Current	-	-	0	0	0	0	0	0	1	2	0	1
Grants Receivable Current	-	-	-	-	-	-	-	0	3	3	3	-
Other Receivables Net Current	-	-	-	-	-	-	-	1	0	2	2	-
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	-	-	-	-	-	0	0	0	2	2
Short Term Investments	63	55	-	-	-	-	-	0	0	0	9	12
Prepaid Expense And Other Assets Current	2	1	1	1	1	2	2	0	1	3	0	9
Assets Current	253	263	59	67	74	79	88	-	-	-	8	59
Operating Lease Right Of Use Asset	0	1	1	-	-	-	0	-	-	-	-	0
Assets	254	264	60	67	74	79	88	21	25	29	8	59
Liabilities
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Current
Accounts Payable Current	7	5	5	3	5	4	5	1	1	2	1	3
Other Assets Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Derivative Liabilities Current	0	0	2	2	2	2	2	-	-	-	0	-
Operating Lease Liability Current	0	0	0	-	-	-	0	-	-	-	0	12
Liabilities Current	12	9	11	10	10	9	12	4	6	8	2	29
Operating Lease Liability Noncurrent	0	0	0	-	-	-	0	-	-	-	0	0
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	0	-	-	-	71	-
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Derivative Liabilities Noncurrent	2	2	2	2	2	2	2	-	-	-	1	-
Liabilities	37	31	32	28	26	24	26	-	-	-	11	29
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	-	-	0	1
Preferred Stock Value	-	-	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	390	383	163	161	159	157	156	343	343	342	2	341
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	-0	-0	0	-0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-173	-151	-135	-123	-111	-102	-94	-326	-323	-320	-76	-310
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	0	-	-	-	0	-
Stockholders Equity	217	232	28	39	48	56	63	-87	-81	-77	-74	31
Liabilities And Stockholders Equity	254	264	60	67	74	79	88	21	25	29	8	59
Temporary Equity Shares Authorized	-	-	-	-	-	-	0	-	-	-	21	-
Preferred Stock Par Or Stated Value Per Share	-	0.001	0.001	0.001	0.001	0.001	0.001	-	-	-	0.001	-
Temporary Equity Shares Issued	-	-	-	-	-	-	0	-	-	-	15	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-	-	-	0	-
Preferred Stock Shares Authorized	-	10	10	10	10	10	10	-	-	-	10	-
Temporary Equity Shares Outstanding	-	-	-	-	-	-	0	-	-	-	15	-
Preferred Stock Shares Issued	-	-	0	0	0	0	0	-	-	-	0	-
Temporary Equity Liquidation Preference	-	-	-	-	-	-	0	-	-	-	65	-
Common Stock Shares Authorized	200	200	200	200	200	200	200	-	-	-	9	-
Common Stock Shares Issued	14	14	12	11	11	11	5	-	-	-	2	-
Preferred Stock Shares Outstanding	-	0	0	0	0	0	0	-	-	-	0	-
Shares Outstanding	14	14	12	11	11	11	11	-	-	-	2	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.59%	30.86%	21.85%	-	-	-	-	-	-	-	-	-
2025	17.54%	11.61%	69.13%	20.78%	42.69%	73.19%	23.24%	22.98%	-5.95%	-0.85%	-8.55%	-9.27%
2024	-9.85%	-26.12%	52.95%	1.73%	-2.93%	3.28%	1.43%	-17.70%	-19.25%	-9.29%	-15.26%	-21.22%
2023	-	-	-	53.10%	31.86%	0.88%	-21.20%	-29.60%	-27.20%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	21.18	28.88	5.20	6.49	7.67	8.84	7.33	-	-	-	3.20	2.05
Quick Ratio	20.97	28.73	5.11	6.38	7.53	8.64	7.14	-	-	-	3.11	1.73
Working Capital	241.08M	254.12M	47.64M	56.63M	64.13M	70.46M	76.20M	-	-	-	5.19M	30.22M
Leverage & Debt
Debt to Equity	0.17	0.14	1.13	0.73	0.54	0.43	0.41	-0.05	-0.08	-0.10	-0.15	0.95
Interest Coverage TTM	-13.79	-15.66	-14.90	-14.07	-14.41	-17.10	-21.04	3.87	-2.43	1.09	-6.41	-21.05
Debt Ratio	0.14	0.12	0.53	0.42	0.35	0.30	0.29	-	-	-	1.51	0.49
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	0.75	0.55
Days Sales Outstanding TTM	-	-	-	-	-	-	21,778.33	245.99	26.76	14.40	-	7.89
Receivables Turnover TTM	-	-	-	-	-	-	0.02	1.48	13.64	25.34	-	46.29
Per Share Metrics
Diluted EPS TTM	-4.30	-3.77	-3.71	-2.94	-2.55	-2.08	-7.83	14.00	11.86	16.46	10.42	-22.70
Free Cash Flow Per Share TTM	-2.54	-2.22	-2.22	-2.30	-1.84	-1.50	-4.87	8.47	4.48	-2.24	-7.85	-38.25
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-234,916.67%	347.62%	-18.58%	5.13%	-30.66%	-84.78%
Net Profit Margin TTM	-	-	-	-	-	-	-290,566.67%	2,355.42%	126.32%	79.40%	48.28%	-64.70%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-99.98%	-97.57%	-49.51%	125.21%	51.99%	57.66%
Net Income Growth (1Y)	118.87%	115.37%	139.27%	-231.42%	-234.25%	-178.54%	-193.27%	-188.30%	-177.63%	-170.47%	-156.17%	-19.15%
EPS Growth (1Y)	68.51%	81.28%	-52.66%	-121.03%	-121.50%	-112.62%	-174.18%	-161.66%	-148.02%	-137.06%	-2,453.50%	4,766.57%
Valuation Metrics
P/E TTM	-35.56	-33.09	-28.23	-21.30	-8.84	-13.47	-1.53	1.18	0.83	0.89	1.38	-1.05
P/B TTM	10.12	7.02	42.09	17.93	5.21	5.55	0.43	-0.34	-0.21	-0.34	-0.35	0.97
P/S TTM	-	-	-	-	-	-	4,451.87	27.90	1.04	0.71	0.67	0.68
Market Cap	2.19B	1.63B	1.18B	693.62M	249.13M	308.27M	26.71M	29.35M	17.37M	25.92M	25.77M	29.47M
Enterprise Value	2.01B	1.42B	1.12B	630.05M	178.70M	232.65M	-56.89M	9.99M	-2.36M	6.83M	18.42M	-3.43M
Calculated Values
Free Cash Flow TTM	-36.51M	-29.10M	-25.01M	-25.47M	-20.34M	-16.51M	-10.84M	14.99M	7.94M	-3.96M	-13.90M	-47.28M
Net Debt	-187.80M	-206.39M	-57.98M	-63.57M	-70.43M	-75.63M	-83.60M	-19.36M	-19.73M	-19.08M	-7.35M	-32.89M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-17Sale

Owner: Goin, Kathleen

Title: Chief Operating Officer

Shares: 4,302

Price/Share: $111.27

Value: $478,683.54

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-05-20Sale

Owner: Goin, Kathleen

Title: Chief Operating Officer

Shares: 4,302

Price/Share: $111.18

Value: $478,296.36

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-04-15Sale

Owner: Goin, Kathleen

Title: Chief Operating Officer

Shares: 4,302

Price/Share: $128.16

Value: $551,344.32

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-03-30Purchase

Owner: Jenkins, George M

Title: -

Shares: 445

Price/Share: $112.30

Value: $49,973.50

Shares Owned: 187,616

Relationship: Director

Ownership: Direct

2026-03-18Sale

Owner: Goin, Kathleen

Title: Chief Operating Officer

Shares: 4,302

Price/Share: $118.34

Value: $509,098.68

Shares Owned: -

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-17	Goin, Kathleen	Officer	Chief Operating Officer	Direct	Sale	4,302	111.27	$478,683.54	0	4
2026-05-20	Goin, Kathleen	Officer	Chief Operating Officer	Direct	Sale	4,302	111.18	$478,296.36	0	4
2026-04-15	Goin, Kathleen	Officer	Chief Operating Officer	Direct	Sale	4,302	128.16	$551,344.32	0	4
2026-03-30	Jenkins, George M	Director	-	Direct	Purchase	445	112.30	$49,973.50	187,616	4
2026-03-18	Goin, Kathleen	Officer	Chief Operating Officer	Direct	Sale	4,302	118.34	$509,098.68	0	4
2026-02-27	Jenkins, George M	Director	-	Direct	Purchase	4,000	125.00	$500,000.00	187,171	4
2026-02-27	Heron, Elaine J	Director	-	Direct	Purchase	2,400	125.00	$300,000.00	47,812	4
2026-02-18	Goin, Kathleen	Officer	Chief Operating Officer	Direct	Sale	4,302	79.56	$342,267.12	0	4
2026-01-21	Goin, Kathleen	Officer	Chief Operating Officer	Direct	Sale	4,302	96.72	$416,089.44	0	4
2025-12-17	Goin, Kathleen	Officer	Chief Operating Officer	Direct	Sale	4,302	96.47	$415,013.94	0	4
2025-11-19	Goin, Kathleen	Officer	Chief Operating Officer	Direct	Sale	4,302	86.12	$370,488.24	0	4
2025-04-09	Jenkins, George M	Director	-	Direct	Purchase	2,500	20.13	$50,325.00	183,171	4
2024-12-18	Jenkins, George M	Director	-	Direct	Purchase	4,000	12.93	$51,720.00	180,671	4
2024-08-12	Adar1, Capital Management…	TenPercentOwner	-	Indirect	Purchase	3,000	15.88	$47,640.00	129,574	4
2024-08-07	Geraghty, James A	Director	-	Direct	Purchase	1	1.00	$1.00	1	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

97.57%

Inst. Shares: 12,767,444

Shares Outstanding: 13,085,271

2025-12-31

86.65%

Inst. Shares: 9,749,410

Shares Outstanding: 11,251,250

2025-09-30

77.02%

Inst. Shares: 8,521,579

Shares Outstanding: 11,064,282

2025-06-30

53.31%

Inst. Shares: 5,892,410

Shares Outstanding: 11,052,741

2025-03-31

46.52%

Inst. Shares: 5,123,331

Shares Outstanding: 11,013,697

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	12,767,444	13,085,271	97.57%
2025-12-31	9,749,410	11,251,250	86.65%
2025-09-30	8,521,579	11,064,282	77.02%
2025-06-30	5,892,410	11,052,741	53.31%
2025-03-31	5,123,331	11,013,697	46.52%
2024-12-31	4,031,505	2,225,934	181.12%
2024-09-30	602,518	1,770,167	34.04%
2024-06-30	352,134	1,770,167	19.89%
2024-03-31	35,352,461	1,770,167	-
2023-12-31	36,396,924	1,770,167	-
2023-09-30	38,989,155	1,236,000	-
2023-06-30	47,043,574	1,095,000	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

PALVELLA THERAPEUTICS, INC. (PVLA) — SEC Financial Statements & Analysis

PALVELLA THERAPEUTICS, INC. (PVLA) is a pharmaceutical preparations company, incorporated in NV. PALVELLA THERAPEUTICS, INC. trades on Nasdaq as: PVLA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PALVELLA THERAPEUTICS, INC. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.17x, a Price-to-Sales (P/S) ratio of 4451.87x (TTM), a Price-to-Book (P/B) ratio of 10.12x (TTM), at a market cap of $2.19B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.17x
P/S TTM: 4451.87x
P/B TTM: 10.12x
Market Cap: $2.19B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PALVELLA THERAPEUTICS, INC. in?

PALVELLA THERAPEUTICS, INC. (PVLA) operates in the Pharmaceutical Preparations industry.

What is PVLA's market cap?

PALVELLA THERAPEUTICS, INC. (PVLA) has a market capitalization of $2.19B as of 2026-06-30.

What exchange does PVLA trade on?

PALVELLA THERAPEUTICS, INC. (PVLA) trades on the Nasdaq.

Where is PALVELLA THERAPEUTICS, INC. incorporated?

PALVELLA THERAPEUTICS, INC. is incorporated in NV.